Shanghai - Delayed Quote CNY
Zhejiang Jiuzhou Pharmaceutical Co., Ltd (603456.SS)
13.86
-0.01
(-0.07%)
At close: 3:00:01 PM GMT+8
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Yi Jiang Mei | President & Director | -- | -- | 1975 |
Mr. Yujie Sha | VP, Financial Director & Director | -- | -- | 1981 |
Mr. Huilu Lin | VP, Secretary of the Board of Directors & Director | -- | -- | 1974 |
Dr. Yuanqiang Li | VP & Director | -- | -- | 1968 |
Mr. Nonggang Yang | Vice President | -- | -- | 1975 |
Ms. Minxia Huang | Vice President | -- | -- | 1976 |
Mr. Gong Chen | Vice President | -- | -- | 1982 |
Zhejiang Jiuzhou Pharmaceutical Co., Ltd
No. 99 Waisha Road
Jiaojiang District
Taizhou, 318000
China
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 5,001
Description
Zhejiang Jiuzhou Pharmaceutical Co., Ltd operates as contract development and manufacturing organization company in China and internationally. The company offers small molecule chemical drugs, peptide drugs, conjugated drugs, and small nucleic acid drugs. It serves global pharmaceutical companies, biotechnology companies, and research institutions. Zhejiang Jiuzhou Pharmaceutical Co., Ltd was founded in 1973 and is headquartered in Taizhou, China.
Corporate Governance
Zhejiang Jiuzhou Pharmaceutical Co., Ltd’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
April 15, 2025 at 10:59 AM UTC
Zhejiang Jiuzhou Pharmaceutical Co., Ltd Earnings Date
Recent Events
July 4, 2024 at 12:00 AM UTC
Ex-Dividend Date